WCN25-1924 IS MULTI-ORGAN SUPPORT ALWAYS A TRANSPLANT BRIDGING TREATMENT IN CIRRHOSIS, OR DO WE HAVE TO KNOW WHEN TO STOP?: CASE REPORT
Liver cirrhosis is a common pathology in the mexican population, its main origins are due to NASH or associated with alcohol consumption. Patients with cirrhosis usually have liver disease with failure of other organs such as the kidney and heart. Although the treatment of hepatorenal syndrome seeks reversibility at all costs, it is a reality that the definitive treatment is a liver transplant when reversibility is no longer possible. Management with RRT or liver support has become an increasingly common option as a transplant bridging therapy.
Authors
- Linda E. Muñoz‐Espinosa (ORCID: https://orcid.org/0000-0002-0455-9325)
- Mara Cecilia Olivo Gutiérrez
- Paola Borbolla-Flores (ORCID: https://orcid.org/0000-0002-2476-7172)
- Nayeli Nicte López-Villa
- Lilia María Rizo-Topete
- Kenya Yamilleth Rodríguez Ibarra
- Juan Pablo Gómez-Villareal
- Irma Isabel Flores-Ponzio
Institutions
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.095
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00